These findings suggest the potential therapeutic application of IL-6 inhibitors to enhance the responsiveness to chemotherapy in GC.[27] In this study, we observed that the serum SAA and IL-6 levels decreased significantly after treatment. The gene discussed is IL6; the disease is gastric cancer.